Tfo Tdc, LLC Gilead Sciences, Inc. Transaction History

Tfo Tdc, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$71.58 - $87.29 $1.15 Million - $1.4 Million	-16,045 Reduced 99.91%	15 $1,000
Q4 2023 Feb 12, 2024	BUY	$73.27 - $83.09 $1.17 Million - $1.33 Million	16,006 Added 29640.74%	16,060 $1.3 Million
Q3 2023 Nov 02, 2023	BUY	$73.94 - $80.67 $2,883 - $3,146	39 Added 260.0%	54 $4,000
Q1 2023 May 03, 2023	BUY	$77.31 - $88.08 $1,082 - $1,233	14 Added 1400.0%	15 $1,000
Q4 2022 Feb 03, 2023	BUY	$62.32 - $89.47 $62 - $89	1 New	1 $0
Q2 2022 Jul 18, 2022	BUY	$57.72 - $65.01 $346 - $390	6 Added 1.33%	456 $28,000
Q1 2022 Apr 25, 2022	BUY	$57.92 - $72.58 $26,064 - $32,661	450 New	450 $27,000
Q4 2021 Jan 21, 2022	SELL	$64.88 - $73.64 $29,195 - $33,138	-450 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$67.69 - $73.03 $16,922 - $18,257	250 Added 125.0%	450 $31,000
Q2 2021 Jul 14, 2021	SELL	$63.47 - $69.35 $15,867 - $17,337	-250 Reduced 55.56%	200 $14,000
Q4 2020 Jan 29, 2021	BUY	$56.65 - $64.55 $25,492 - $29,047	450 New	450 $26,000
Q2 2020 Jul 17, 2020	SELL	$72.34 - $84.0 $36,604 - $42,504	-506 Closed	0 $0
Q1 2020 Apr 20, 2020	BUY	$62.63 - $80.22 $3,507 - $4,492	56 Added 12.44%	506 $37,000
Q4 2019 Jan 27, 2020	BUY	$61.62 - $67.78 $27,729 - $30,501	450 New	450 $29,000

1,931

991M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Tfo Tdc, LLC, based on Form 13F filings with the SEC.

Stay updated on Tfo Tdc, LLC with notifications on news.